BCB Bancorp vs Northrim Bancorp
BCBP and NRIM side by side, both in savings institutions. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BCBP and NRIM compare
Northrim Bancorp is the larger company, worth 3.1 times as much as BCB Bancorp ($511M against $165M).
Northrim Bancorp grew revenue faster over the last twelve months (3.2% versus 2.2% for BCB Bancorp).
Northrim Bancorp keeps more of each dollar of sales as profit, with a net margin of 21.8% compared with −17.6% at BCB Bancorp.
Both pay dividends: BCB Bancorp yields 1.8% and Northrim Bancorp 2.8%.
Northrim Bancorp scores higher on the StockData Score (19 against 6 for BCB Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BCBP | NRIM |
|---|---|---|
| Size and price | ||
| Market cap | $165M | $511M |
| Share price | $9.13 | $22.95 |
| Change, 1 year | 18.7% | −1.7% |
| Change, 5 years | −38.8% | 114% |
| Beta (5Y) | −0.21 | 0.36 |
| Employees | 295 | 516 |
| StockData Score | ||
| Total score | 6 | 19 (better) |
| Valuation score | 2 | 4 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 5 (better) |
| Health score | 1 | 4 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | – | 9.3× |
| P/S | 1.6× (better) | 2.0× |
| P/B | 0.6× (better) | 1.4× |
| P/FCF | 4.8× (better) | 6.2× |
| PEG | – | 0.31 |
| FCF yield | 20.7% (better) | 16.1% |
| Fair value | – | $24.63 |
| Margin of safety | – | 6.8% |
| Growth | ||
| Revenue growth (TTM) | 2.2% | 3.2% (better) |
| Revenue growth, 5Y average | 1.8% | 13.8% (better) |
| Net income growth (TTM) | −441% | −11.5% (better) |
| EPS growth (TTM) | −679% | −12.1% (better) |
| EPS growth, 5Y average | – | 17.6% |
| Profitability | ||
| Gross margin | – | 79.2% |
| Net margin | −17.6% | 21.8% (better) |
| FCF margin | 34.1% (better) | 32.0% |
| Return on equity | −5.8% | 16.6% (better) |
| Financial health | ||
| Altman Z-score | 0.11 | 0.30 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.8% | 2.8% (better) |
| Payout ratio | – | 26.6% |
| Years of dividend growth | 0 | 15 (better) |
| Dividend growth, 5Y average | 2.7% | 13.2% (better) |
| Buyback yield | −0.54% | −0.17% (better) |
| Shareholder yield | 1.2% | 2.7% (better) |
| Ownership | ||
| Held by institutions | 43.7% | 74.1% |
| Held by insiders | 19.4% | 2.4% |
| Insider net buying, 12 months | $1.4M (better) | −$410K |
| Short interest, % of float | 11.0% | 5.5% |
Go deeper
- BCBP stock overview
- BCBP income statement
- BCBP valuation and score
- NRIM stock overview
- NRIM income statement
- NRIM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.